279 related articles for article (PubMed ID: 29243585)
1. Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma.
Alexander N; Vali R; Ahmadzadehfar H; Shammas A; Baruchel S
Curr Radiopharm; 2018; 11(1):14-21. PubMed ID: 29243585
[TBL] [Abstract][Full Text] [Related]
2. Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma.
Kong G; Hofman MS; Murray WK; Wilson S; Wood P; Downie P; Super L; Hogg A; Eu P; Hicks RJ
J Pediatr Hematol Oncol; 2016 Mar; 38(2):87-96. PubMed ID: 26296147
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and Therapeutic Potential of Combined Peptide Receptor Radionuclide Therapy With Intensive Chemotherapy for Pediatric Patients With Relapsed or Refractory Metastatic Neuroblastoma.
Fathpour G; Jafari E; Hashemi A; Dadgar H; Shahriari M; Zareifar S; Jenabzade AR; Vali R; Ahmadzadehfar H; Assadi M
Clin Nucl Med; 2021 Jul; 46(7):540-548. PubMed ID: 33782280
[TBL] [Abstract][Full Text] [Related]
4. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
Kroiss A; Putzer D; Uprimny C; Decristoforo C; Gabriel M; Santner W; Kranewitter C; Warwitz B; Waitz D; Kendler D; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):865-73. PubMed ID: 21279352
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy.
Gains JE; Aldridge MD; Mattoli MV; Bomanji JB; Biassoni L; Shankar A; Gaze MN
Nucl Med Commun; 2020 Nov; 41(11):1169-1177. PubMed ID: 32796449
[TBL] [Abstract][Full Text] [Related]
6. 177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
Gains JE; Bomanji JB; Fersht NL; Sullivan T; D'Souza D; Sullivan KP; Aldridge M; Waddington W; Gaze MN
J Nucl Med; 2011 Jul; 52(7):1041-7. PubMed ID: 21680680
[TBL] [Abstract][Full Text] [Related]
7.
Maaz AUR; O'Doherty J; Djekidel M
J Nucl Med Technol; 2021 Sep; 49(3):265-268. PubMed ID: 33820858
[TBL] [Abstract][Full Text] [Related]
8.
AlSadi R; Maaz AUR; Bouhali O; Djekidel M
J Nucl Med Technol; 2023 Jun; 51(2):140-146. PubMed ID: 37192823
[No Abstract] [Full Text] [Related]
9. Pediatric applications of Dotatate: early diagnostic and therapeutic experience.
McElroy KM; Binkovitz LA; Trout AT; Czachowski MR; Seghers VJ; Lteif AN; States LJ
Pediatr Radiol; 2020 Jun; 50(7):882-897. PubMed ID: 32495176
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
Velikyan I; Sundin A; Sörensen J; Lubberink M; Sandström M; Garske-Román U; Lundqvist H; Granberg D; Eriksson B
J Nucl Med; 2014 Feb; 55(2):204-10. PubMed ID: 24379222
[TBL] [Abstract][Full Text] [Related]
11. PET/CT imaging in neuroblastoma.
Piccardo A; Lopci E; Conte M; Foppiani L; Garaventa A; Cabria M; Villavecchia G; Fanti S; Cistaro A
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):29-39. PubMed ID: 23474633
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-DOTATATE PET in neuroectodermal tumours: first experience.
Win Z; Al-Nahhas A; Towey D; Todd JF; Rubello D; Lewington V; Gishen P
Nucl Med Commun; 2007 May; 28(5):359-63. PubMed ID: 17414885
[TBL] [Abstract][Full Text] [Related]
13. Gamma Emitters in Pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides?
Briganti V; Cuccurullo V; Di Stasio GD; Mansi L
Curr Radiopharm; 2019; 12(2):156-170. PubMed ID: 30827276
[TBL] [Abstract][Full Text] [Related]
14. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
[TBL] [Abstract][Full Text] [Related]
15. 68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.
Provost C; Prignon A; Cazes A; Combaret V; Delattre O; Janoueix-Lerosey I; Montravers F; Talbot JN
Anticancer Res; 2016 Sep; 36(9):4459-66. PubMed ID: 27630282
[TBL] [Abstract][Full Text] [Related]
16. Imaging-Guided Use of Combined
Ashwathanarayana AG; Biswal CK; Sood A; Parihar AS; Kapoor R; Mittal BR
J Nucl Med Technol; 2017 Dec; 45(4):314-316. PubMed ID: 28798226
[TBL] [Abstract][Full Text] [Related]
17. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704
[TBL] [Abstract][Full Text] [Related]
18. The Complementary Role of 68Ga-DOTATATE PET/CT in Neuroblastoma.
Telli T; Lay Ergün E; Volkan Salanci B; Özgen Kiratli P
Clin Nucl Med; 2020 Apr; 45(4):326-329. PubMed ID: 31977455
[TBL] [Abstract][Full Text] [Related]
19. Cardiac metastases of neuroendocrine tumors treated with 177Lu DOTATATE peptide receptor radionuclide therapy or 131I-MIBG therapy.
Makis W; McCann K; Bryanton M; McEwan AJ
Clin Nucl Med; 2015 Dec; 40(12):962-4. PubMed ID: 26359563
[TBL] [Abstract][Full Text] [Related]
20. Selective use of Peptide Receptor Radionuclide Therapy following comparative imaging of Ga-68 DOTATATE PET/CT against I-131 MIBG scintigraphy in a small Asian cohort of Adult Neuroblastoma.
Koo SX; Tong AK; Soh SY; Farid M; Loh A; Loke KS
Med J Malaysia; 2021 Jul; 76(4):573-577. PubMed ID: 34305122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
